Raul R. Mena

Hematology
181 S Buena Vista St Fl 4
Burbank, CA 91505

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications

The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma.

The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma.

Journal: British journal of haematology
Published: September 13, 2019

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 27, 2018

Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue.

Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue.

Journal: PloS one
Published: February 28, 2012
Showing 1-3 of 3

Last Updated: 09/26/2026